Last quarter (Q4 2022), Noxopharm Ltd.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Noxopharm Ltd.'s net income was $―. See Noxopharm Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ ―	$ 15.21M	$ 20.21M	$ 16.37M	$ 15.68M	$ 10.51M
Operating Income	$ ―	$ -15.21M	$ -20.21M	$ -16.37M	$ -15.68M	$ -10.51M
Net Non Operating Interest Income Expense	$ ―	$ -30.39K	$ -2.05M	$ -3.46M	$ -464.21K	$ -175.49K
Other Income Expense	$ ―	$ -3.43M	$ 12.91M	$ 18.82M	$ 3.57M	$ -7.64M
Pretax Income	$ ―	$ -18.67M	$ -9.35M	$ -999.57K	$ -12.57M	$ -18.32M
Tax Provision	$ ―	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ -18.67M	$ -9.35M	$ -272.09K	$ -11.22M	$ -18.28M
Basic EPS	$ ―	$ -0.06	$ -0.04	$ >-0.01	$ -0.08	$ ―
Diluted EPS	$ ―	$ -0.06	$ -0.04	$ >-0.01	$ -0.08	$ ―
Basic Average Shares	$ ―	$ 291.22M	$ 263.85M	$ 138.36M	$ 138.15M	$ ―
Diluted Average Shares	$ ―	$ 291.22M	$ 263.85M	$ 138.36M	$ 138.15M	$ ―
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income From Continuing And Discontinued Operation	$ ―	$ -18.67M	$ -9.35M	$ -272.09K	$ -11.22M	$ -18.28M
Normalized Income	$ ―	$ -18.67M	$ -9.35M	$ -272.09K	$ -11.22M	$ -18.28M
Interest Expense	$ ―	$ 77.33K	$ 2.19M	$ 3.47M	$ 650.90K	$ 238.30K
EBIT	$ ―	$ -18.59M	$ -7.16M	$ 2.47M	$ -11.92M	$ -18.08M
EBITDA	$ ―	$ -18.33M	$ -6.90M	$ 2.71M	$ -11.86M	$ -18.02M

Currency in USD

Noxopharm Ltd. Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing